D. Karaiskos

620 total citations
21 papers, 437 citations indexed

About

D. Karaiskos is a scholar working on Psychiatry and Mental health, Clinical Psychology and Epidemiology. According to data from OpenAlex, D. Karaiskos has authored 21 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in Clinical Psychology and 4 papers in Epidemiology. Recurrent topics in D. Karaiskos's work include Eating Disorders and Behaviors (3 papers), Obsessive-Compulsive Spectrum Disorders (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). D. Karaiskos is often cited by papers focused on Eating Disorders and Behaviors (3 papers), Obsessive-Compulsive Spectrum Disorders (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). D. Karaiskos collaborates with scholars based in Greece and United States. D. Karaiskos's co-authors include Thomas Paparrigopoulos, Elias Tzavellas, Ioannis Liappas, Ιoannis Ilias, Haralampos Μ. Moutsopoulos, Clio P. Mavragani, Georgia Kourlaba, Michalis Voulgarelis, Nikolaos Kokras and J. Liappas and has published in prestigious journals such as Annals of the Rheumatic Diseases, The Journal of Clinical Psychiatry and Lara D. Veeken.

In The Last Decade

D. Karaiskos

20 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Karaiskos Greece 10 126 73 61 55 52 21 437
Siân Lewis United Kingdom 11 196 1.6× 47 0.6× 65 1.1× 123 2.2× 11 0.2× 20 713
Guihong Wang China 10 182 1.4× 35 0.5× 26 0.4× 63 1.1× 31 0.6× 25 524
Muhammad Ismail Ireland 10 34 0.3× 63 0.9× 21 0.3× 54 1.0× 13 0.3× 40 533
Simon Outram United States 13 79 0.6× 59 0.8× 24 0.4× 51 0.9× 54 1.0× 47 510
Tomohiro Shirasaka Japan 10 189 1.5× 33 0.5× 13 0.2× 92 1.7× 13 0.3× 28 494
Tuğba Seda Çolak Türkiye 8 171 1.4× 29 0.4× 65 1.1× 97 1.8× 7 0.1× 34 438
Önder Öztürk Türkiye 14 138 1.1× 69 0.9× 97 1.6× 42 0.8× 6 0.1× 60 667
Charlotte Haws United States 7 199 1.6× 111 1.5× 38 0.6× 151 2.7× 5 0.1× 8 486
Aaron J. Roberto United States 6 68 0.5× 65 0.9× 20 0.3× 60 1.1× 31 0.6× 8 438
Dolores Perdomo United States 13 81 0.6× 284 3.9× 22 0.4× 135 2.5× 40 0.8× 21 566

Countries citing papers authored by D. Karaiskos

Since Specialization
Citations

This map shows the geographic impact of D. Karaiskos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Karaiskos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Karaiskos more than expected).

Fields of papers citing papers by D. Karaiskos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Karaiskos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Karaiskos. The network helps show where D. Karaiskos may publish in the future.

Co-authorship network of co-authors of D. Karaiskos

This figure shows the co-authorship network connecting the top 25 collaborators of D. Karaiskos. A scholar is included among the top collaborators of D. Karaiskos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Karaiskos. D. Karaiskos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tzavellas, Elias, D. Karaiskos, Ιoannis Ilias, Ioannis Liappas, & Thomas Paparrigopoulos. (2016). Agomelatine augmentation in obsessive compulsive disorder: a preliminary report.. PubMed. 25(3). 179–84. 5 indexed citations
2.
Karaiskos, D., Dimitra Pappa, Kostas Siarkos, et al.. (2014). EPA-1197 – Agomelatine for treating apathy in alzheimer's disease. European Psychiatry. 29. 1–1. 4 indexed citations
3.
Havaki-Kontaxaki, B.J., et al.. (2014). Glandular cystitis and lithium intoxication in a patient with bipolar disorder.. PubMed. 23(2). 158–61.
4.
Paparrigopoulos, Thomas, et al.. (2013). Increased co-morbidity of depression and post-traumatic stress disorder symptoms and common risk factors in intensive care unit survivors: A two-year follow-up study. International Journal of Psychiatry in Clinical Practice. 18(1). 25–31. 40 indexed citations
5.
Tzavellas, Elias, et al.. (2013). 2148 – Agomelatine Augmentation In Obsessive Compulsive Disorder. European Psychiatry. 28(S1). 1 indexed citations
6.
Karaiskos, D., Elias Tzavellas, Ιoannis Ilias, Ioannis Liappas, & Thomas Paparrigopoulos. (2013). Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus. International Journal of Clinical Practice. 67(3). 257–260. 26 indexed citations
7.
Karaiskos, D., et al.. (2013). 1373 – Agomelatine And Sertraline For The Treatment Of Depression In Type 2 Diabetes Mellitus. European Psychiatry. 28(S1). 2 indexed citations
8.
Paparrigopoulos, Thomas, Elias Tzavellas, D. Karaiskos, Georgia Kourlaba, & Ioannis Liappas. (2011). Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study. BMC Psychiatry. 11(1). 41–41. 57 indexed citations
9.
Paparrigopoulos, Thomas, et al.. (2011). Tourette syndrome (TS) mimicking tardive dystonia. European Psychiatry. 26(S2). 980–980. 1 indexed citations
10.
Ilias, Ιoannis, et al.. (2011). IGF-I and IGFBP-3 before and after inpatient alcohol detoxification in alcohol-dependent subjects. Medical Science Monitor. 17(10). CR547–CR551. 1 indexed citations
11.
Karaiskos, D., Clio P. Mavragani, Maria Hamze Sinno, et al.. (2010). Psychopathological and personality features in primary Sjogren's syndrome--associations with autoantibodies to neuropeptides. Lara D. Veeken. 49(9). 1762–1769. 39 indexed citations
12.
Paparrigopoulos, Thomas, et al.. (2010). Complete recovery from undertreated Wernicke-Korsakoff syndrome following aggressive thiamine treatment.. PubMed. 24(2). 231–3. 13 indexed citations
13.
Karaiskos, D., et al.. (2010). P02-232 - Social Network Addiction : a New Clinical Disorder?. European Psychiatry. 25(S1). 141 indexed citations
14.
Tzavellas, Elias, D. Karaiskos, Konstantinos Spengos, et al.. (2010). P.2.c.034 Duloxetine versus sertraline in the treatment of post-stroke depression. European Neuropsychopharmacology. 20. S387–S387. 1 indexed citations
15.
Kontaxakis, V.P., D. Karaiskos, B.J. Havaki-Kontaxaki, Panagiotis Ferentinos, & George N. Papadimitriou. (2009). Can Quetiapine-Induced Hypothyroidism be Reversible Without Quetiapine Discontinuation?. Clinical Neuropharmacology. 32(5). 295–296. 11 indexed citations
16.
Tzavellas, Elias, et al.. (2009). P.6.a.01l Sexual dysfunction and alcohol abuse. European Neuropsychopharmacology. 19. S641–S642. 1 indexed citations
17.
Tzavellas, Elias, et al.. (2009). Family Burden in Alcohol Dependence. European Psychiatry. 24(S1). 2 indexed citations
18.
Paparrigopoulos, Thomas, Elias Tzavellas, D. Karaiskos, Petros Malitas, & Ioannis Liappas. (2009). An open pilot study of tiagabine in alcohol dependence: tolerability and clinical effects. Journal of Psychopharmacology. 24(9). 1375–1380. 22 indexed citations
19.
Kontaxakis, V.P., D. Karaiskos, B.J. Havaki-Kontaxaki, et al.. (2009). Quetiapine and Hypothyroidism: A Literature Review. European Psychiatry. 24(S1). 1 indexed citations
20.
Karaiskos, D., et al.. (2008). Stress, coping strategies and social support in patients with primary Sjögren’s syndrome prior to disease onset: a retrospective case–control study. Annals of the Rheumatic Diseases. 68(1). 40–46. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026